戻る
ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (01541.HK)価格
01541.HK 株価推移チャート
IMMUNEONCO-B (01541.HK)
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HK$4.62
-14.12%
$-0.75
休場: Jan 21, 16:00:00 HKT
主要データ
前終値
$5.38
始値
$5.38
当日レンジ
$4.55 - $5.39
52週レンジ
$4.31 - $16.8
取引高
5.4M
平均取引高
2.1M
1株当たり利益(TTM)
-0.93
配当利回り
--
時価総額
$1.9B
IMMUNEONCO-Bとは何ですか？
ImmuneOnco Biopharmaceuticals (Shanghai), Inc. operates as an early-stage biopharmaceutical company which develops and commercializes novel cancer immunotherapeutic products. The company is headquartered in Shanghai, Shanghai and currently employs 195 full-time employees. The company went IPO on 2023-09-05. The firm's main businesses include the development of biotechnology for the systemic utilization of innate and adaptive immunity, and the development of next-generation tumor immunotherapies, which primarily focus on the adaptive immune system. The firm's core product IMM01 is an innovative CD47-targeted molecule. The firm mainly operates its businesses in the domestic and overseas markets.